PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 17, 2025Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition0 citations

Unsupervised Learning to Dissect the Metabolic Heterogeneity in mutant IDH Astrocytoma and Oligodendroglioma Using 3D MRSI

View Full Paper
GUGülnur UnganPWPaul WeiserJDJörg Dietrich

Key Points

  • Distinct clustering patterns for IDH-mutant astrocytomas and oligodendrogliomas were identified, enhancing classification.
  • Utilizing metrics like Silhouette and Davies-Bouldin scores confirmed the effectiveness of the clustering approach.
  • The analysis used 3D MRSI data from nine IDH-mutant glioma cases, focusing on different tumor regions.
  • Findings may guide more tailored treatment strategies in neuro-oncology, highlighting the importance of metabolic imaging.

Abstract

Motivation: Glioma classification, particularly between IDH-mutant astrocytomas (AC) and oligodendrogliomas (OG), is challenging due to overlapping metabolic profiles. Improved differentiation is crucial for accurate tumor identification and treatment planning. Goal(s): To enhance the classification of IDH-mutant AC and OG gliomas by identifying distinct metabolic patterns through advanced imaging and machine learning. Approach: The study analyzed 3D MRSI data from nine IDH-mutant glioma cases using UMAP and clustering metrics, focusing on core and non-core tumor regions. Results: Distinct clustering emerged, with OG showing greater cohesion and clear boundaries, confirmed by Silhouette, Davies-Bouldin, Calinski-Harabasz scores, and entropy measures, enhancing classification capabilities for IDH-mutant gliomas. Impact: This study demonstrates that metabolic imaging combined with unsupervised machine learning effectively differentiates astrocytomas and oligodendrogliomas. Insights into tumor heterogeneity and spatial complexity advance glioma classification and could guide more personalized, subtype-specific treatment strategies in neuro-oncology.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ungan et al. (2025) studied this question.

synapsesocial.com/papers/68d4597b31b076d99fa5cb38https://doi.org/10.58530/2025/0071
Ask AI
Helpful
Bookmark
Share
View Full Paper